NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
NANOVIRICIDES, INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.30−0.08 (-5.80%)
Close on Oct 19, 2026
- Market cap
- $28.93M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.20 (−13.33%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
NANOVIRICIDES, INC. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$7.78M.
Revenue
$0
TTM Q4 2026
Operating income
-$8.31M
TTM Q4 2026
Free cash flow
-$7.78M
TTM Q4 2026
EPS, diluted
-$0.41
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $28.93M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.33
- Dividend yield
- –
- Free cash flow yield
- -26.89%
Fundamentals
- Revenue
- $0
- Net income
- -$8.22M
- EPS, diluted
- -$0.41
- Free cash flow
- -$7.78M
- Book value per share
- $0.39
- Diluted shares
- 22M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$0
Operating income
-$8.31M
Net income
-$8.22M
EPS, diluted
-$0.41
Free cash flow
-$7.78M
Reported period